Evolus (EOLS) Income from Continuing Operations (2017 - 2026)

Evolus (EOLS) reported Income from Continuing Operations of 10674000.0 for Q1 2026, up 43.5% on a YoY basis from 7438333.01 in Q1 2025, and down 8310.77% quarter-over-quarter from 130000.0 in Q4 2025.

Evolus (EOLS) Income from Continuing Operations (2017 - 2026) Analysis & Trends

Evolus has reported Income from Continuing Operations for 10 years, with the latest figure at 10674000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 43.5% year-over-year to 10674000.0; the trailing twelve-month figure through Mar 2026 stood at 43423000.0 (up 22.74% YoY), and the FY2025 full-year result was 51641000.0, down 2.42% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 10674000.0, down from 130000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 130000.0 in Q4 2025, with the low at 23471000.0 in Q2 2022.
  • Historically, Income from Continuing Operations has averaged 14637176.47 across 5 years, with a median of 15737000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 373.41% — and 2025, when it soared 101.91%.
  • Evolus' Income from Continuing Operations stood at 13164000.0 in 2022, then rose by 10.13% to 11831000.0 in 2023, then jumped by 42.6% to 6791000.0 in 2024, then surged by 101.91% to 130000.0 in 2025, then slumped by 8310.77% to 10674000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 10674000.0 (Q1 2026), 130000.0 (Q4 2025), and 15737000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn -10.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.67 Mn
Dec 31, 2025 130,000.00
Sep 30, 2025 -15.74 Mn
Jun 30, 2025 -17.14 Mn
Mar 31, 2025 -18.89 Mn
Dec 31, 2024 -6.79 Mn
Sep 30, 2024 -19.17 Mn
Jun 30, 2024 -11.35 Mn
Mar 31, 2024 -13.11 Mn
Dec 31, 2023 -11.83 Mn
Sep 30, 2023 -16.92 Mn
Jun 30, 2023 -18.14 Mn
Mar 31, 2023 -14.79 Mn
Dec 31, 2022 -13.16 Mn
Sep 30, 2022 -20.28 Mn
Jun 30, 2022 -23.47 Mn
Mar 31, 2022 -17.50 Mn
Dec 31, 2021 -18.18 Mn
Sep 30, 2021 -19.43 Mn
Jun 30, 2021 -15.60 Mn